CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 242 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $1,592 | -44.9% | 49 | -53.8% | 0.00% | -100.0% |
| Q3 2023 | $2,888 | +22.4% | 106 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $2,359 | +29.8% | 106 | +26.2% | 0.00% | 0.0% |
| Q1 2023 | $1,817 | +6.5% | 84 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $1,706 | -14.7% | 84 | -13.4% | 0.00% | 0.0% |
| Q3 2022 | $2,000 | 0.0% | 97 | +10.2% | 0.00% | 0.0% |
| Q2 2022 | $2,000 | 0.0% | 88 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $2,000 | – | 88 | +388.9% | 0.00% | – |
| Q4 2021 | $0 | – | 18 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 18 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 18 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 18 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 18 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 18 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 18 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 18 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,712,176 | $123,147,000 | 6.01% |
| TANAKA CAPITAL MANAGEMENT INC | 74,139 | $1,048,000 | 3.38% |
| S&T BANK/PA | 625,078 | $8,859,000 | 1.92% |
| Parallel Advisors, LLC | 1,277,851 | $18,062,000 | 1.55% |
| AJ WEALTH STRATEGIES, LLC | 595,828 | $8,422,000 | 1.11% |
| Matarin Capital Management, LLC | 891,636 | $12,603,000 | 0.95% |
| Capital Impact Advisors, LLC | 162,544 | $2,370,000 | 0.90% |
| AMI ASSET MANAGEMENT CORP | 775,685 | $10,964,000 | 0.57% |
| Birchview Capital, LP | 50,000 | $707,000 | 0.47% |
| Zebra Capital Management LLC | 25,409 | $359,000 | 0.39% |